Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 8,965 | 7,981 | 6,977 | 6,524 | 6,049 |
| Operating Income | -8,965 | -7,981 | -6,977 | -6,524 | -6,049 |
| Interest Expense | 551 | 547 | 425 | 392 | 392 |
| Other Income | 105 | 42 | -1,136 | 71 | 88 |
| Pre-tax Income | -9,411 | -8,486 | -8,538 | -6,845 | -6,353 |
| Income Tax | N/A | 0 | N/A | -1 | N/A |
| Net Income Continuous | -9,411 | -8,486 | -8,538 | -6,845 | -6,353 |
| Net Income | $-9,411 | $-8,486 | $-8,538 | $-6,845 | $-6,353 |
| EPS Basic Total Ops | -840.00 | -760.00 | -800.00 | -1,420.00 | -680.00 |
| EPS Basic Continuous Ops | -845.06 | -764.40 | -802.33 | -16,998.45 | -683.41 |
| EPS Diluted Total Ops | -840.00 | -760.00 | -800.00 | -1,240.00 | -680.00 |
| EPS Diluted Continuous Ops | -845.06 | -764.40 | -802.33 | -3,250.39 | -683.41 |
| EBITDA(a) | $-8,961 | $-7,976 | $-6,972 | $-6,520 | $-6,046 |